Blue Biotechnology Market Research Report - Global Forecast to 2023

Blue Biotechnology Market Research Report - Global Forecast to 2023

ID: MRFR/HC/0242-HCRR | September, 2018 | Region: Global | 80 pages | Half-Cooked Research Reports

Global Blue Biotechnology market, by Product (Enzymes, Pharma Products, Bulk Chemicals, Biopolymers), by Application (Bio-Engineering, Genomics, Vaccine Development, Drug Discovery, Others), by End-Users (Hospitals, Labs) – Forecast Till 2023


Market Scenario


The global blue biotechnology market is expected to grow significantly during the forecast period (2017–2023).


The combination of science and technology to develop new products used in agriculture, environment, and others are called as biotechnology. Cells and cellular components, organisms are used for the advancement of technology to improve quality of life. The amalgamation of aquatic and marine organisms with technology to avail new sources of energy, develop new drugs, extract new active ingredients or just to increase seafood production and its safety is called as blue biotechnology. It is concerned with creating of new marine technology, exploration of marine organisms to monitor sea environment and health threats to human. Blue biotechnology is helpful in the diagnosis of diseases through microbial testing of microorganisms. It has wide application in the field of life science and healthcare. Blue biotechnology feels like a trending field because it is supple, adaptive, and continuously moving forward.


The applications of blue biotechnology are increasing day by day with the help of high throughput screening and genomics which is applied to tap the diversity of ocean. Tapped resources from oceans are utilized for various purposes such as treatment of AIDS virus, cosmetics, and pharmaceutical sector. The blue biotechnology market is growing rapidly and is projected to rise in upcoming years due to an increase in demand for genetically modified microorganisms. Factors such as developing aquatic renewable energy, the aquatic technology used for monitoring of sea atmosphere boosts the blue biotechnology market. Preserving the marine life from the pollution caused by the mankind is the major restraining factor for the growing market.


Segmentation


The global blue biotechnology market has been segmented on the basis of products, application and by end-user.


On the basis of products, the market has been classified as enzymes, pharma products, bulk chemicals, biopolymers and others.


On the basis of application, the market has been classified as bio-engineering, genomics, vaccine development, drug discovery and others


On the basis of the end-user, the market has been classified as hospitals, pharmaceutical companies


biotechnology companies, research institutes, laboratories, and others.


On the basis of region, the market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.


The European blue biotechnology market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 


The blue biotechnology market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The blue biotechnology market in the Middle East & Africa has been segmented into the Middle East and Africa.


Regional Market Summary


In the blue biotechnology market, North America is anticipated to account for the largest market share and will continue to dominate its top position over the forecast period due to the increasing awareness and the rising demand about the blue biotechnology products in vaccine development. The existence of a huge number of biotechnology companies involved in research and development activities in blue biotechnology, growing demand of aquatic biotechnology in cosmetics manufacturing industry and swelling end users applications like cosmetic, pharmaceutical and others drive the growth of this market. 


The European market is expected to hold the second largest market share. The growing focus on marine technology for the research and development of innovative drug has amplified the growth of blue biotechnology market in the European region.


Whereas the market share in the Asia-Pacific region displays a sturdy growth in this market as blue biotechnology is not much used in various fields. The lack of awareness about the usage of marine microorganisms and their applications slows the market in this region.


The market in the Middle East & Africa is expected to account for the smallest share of the global blue biotechnology market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.


Key Players


Some of the key players in the global blue biotechnology market  are Aker BioMarine (Norway), Marinova (Australia), New England Biolabs (US), PML Applications Ltd. (UK), Sea Run Holdings, Inc.(US), PICES (Canada), Donald Danforth Plant Science Center (US), Shell Marine Products (US), GeoMarine Biotechnologies (India),  GlycoMar (Scotland), Cellgen Biologicals Pvt Ltd. (India), Nurture Aqua Technology Pvt. Ltd. (India), Samudra Biopharma Pvt. Ltd (India), and Sanosil Biotech (India).


Global Blue Biotechnology Market, by Products



  • Enzymes

  • Pharma Products

  • Bulk Chemicals

  • Biopolymers

  • Others


Global Blue Biotechnology Market, by Application



  • Bio-Engineering

  • Genomics

  • Vaccine Development

  • Drug Discovery

  • Others


Global Blue Biotechnology Market, by End-Users



  • Hospitals

  • Pharmaceutical Companies

  • Biotechnology Companies

  • Research Institutes

  • Laboratories

  • Others


Global Blue Biotechnology Market, by Region



  • Americas

  • North America

  • US

  • Canada

  • South America

  • Europe

  • Western Europe

  • Germany

  • France

  • Italy

  • Spain

  • UK

  • Rest of Western Europe

  • Eastern Europe

  • Asia-Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Rest of Asia-Pacific

  • The Middle East & Africa

  • Middle East

  • Africa


Intended Audience



  • Biotechnology Companies

  • Biotechnology Research Centers

  • Contract Research Organizations (CROs)

  • Research and Development (R&D) Companies

  • Academic Medical Institutes and Universities

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Blue Biotechnology Market Information, by Products

6.1 Introduction

Market Estimates & Forecast, by Region, 2017–2023

Market Estimates & Forecast, by Country, 2017–2023

6.2 Enzymes

Market Estimates & Forecast, by Region, 2017–2023

Market Estimates & Forecast, by Country, 2017–2023

6.3 Pharma Products

Market Estimates & Forecast, by Region, 2017–2023

Market Estimates & Forecast, by Country, 2017–2023

6.4 Bulk Chemicals

Market Estimates & Forecast, by Region, 2017–2023

Market Estimates & Forecast, by Country, 2017–2023

6.5 Biopolymers

Market Estimates & Forecast, by Region, 2017–2023

Market Estimates & Forecast, by Country, 2017–2023

6.6 Others

Market Estimates & Forecast, by Region, 2017–2023

Market Estimates & Forecast, by Country, 2017–2023

Chapter 7. Global Blue Biotechnology Market Information, by Application

7.1 Introduction

Market Estimates & Forecast, by Region, 2017–2023

Market Estimates & Forecast, by Country, 2017–2023

7.2 Bio-Engineering

Market Estimates & Forecast, by Region, 2017–2023

Market Estimates & Forecast, by Country, 2017–2023

7.3 Genomics

Market Estimates & Forecast, by Region, 2017–2023

Market Estimates & Forecast, by Country, 2017–2023

7.4 Vaccine Development

Market Estimates & Forecast, by Region, 2017–2023

Market Estimates & Forecast, by Country, 2017–2023

7.5 Drug Discovery

Market Estimates & Forecast, by Region, 2017–2023

Market Estimates & Forecast, by Country, 2017–2023

7.6 Others

Market Estimates & Forecast, by Region, 2017–2023

Market Estimates & Forecast, by Country, 2017–2023

Chapter 8. Global Blue Biotechnology Market Information, by Application

8.1 Introduction

8.2 Hospitals

Market Estimates & Forecast, by Region, 2017–2023

Market Estimates & Forecast, by Country, 2017–2023

8.3 Pharmaceutical Companies

Market Estimates & Forecast, by Region, 2017–2023

Market Estimates & Forecast, by Country, 2017–2023

8.4 Biotechnology Companies

Market Estimates & Forecast, by Region, 2017–2023

Market Estimates & Forecast, by Country, 2017–2023

8.5 Research Institutes

Market Estimates & Forecast, by Region, 2017–2023

Market Estimates & Forecast, by Country, 2017–2023

8.6 Laboratories

Market Estimates & Forecast, by Region, 2017–2023

Market Estimates & Forecast, by Country, 2017–2023

8.7 Others

Market Estimates & Forecast, by Region, 2017–2023

Market Estimates & Forecast, by Country, 2017–2023

Chapter 9. Global Blue Biotechnology Market Information, by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 US

9.2.1.2 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia-Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 South Korea

9.4.6 Rest of Asia-Pacific

9.5 Middle East & Africa

9.5.1 Middle East

9.5.2 Africa

Chapter 10. Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

Chapter 11. Company Profiles

11.1 Aker BioMarine

11.1.1 Company Overview

11.1.2 Products Overview

11.1.3 Financials Overview

11.1.4 Key Developments

11.1.5 SWOT Analysis

11.2 Marinova

11.2.1 Company Overview

11.2.2 Products Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 New England Biolabs

11.3.1 Company Overview

11.3.2 Products Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 PML Applications Ltd.

11.4.1 Company Overview

11.4.2 Technology/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 Sea Run Holdings, Inc.

11.5.1 Company Overview

11.5.2 Products Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.6 PICES

11.6.1 Company Overview

11.6.2 Products Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.7 Donald Danforth Plant Science Center

11.7.1 Overview

11.7.2 Products Overview

11.7.3 Financial Overview

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 Shell Marine Products

11.8.1 Overview

11.8.2 Products/ Technology Overview

11.8.3 Financials

11.8.4 Key Developments

11.8.5 SWOT Analysis

11.9 GeoMarine Biotechnologies

11.9.1 Overview

11.9.2 Products Overview

11.9.3 Financials

11.9.4 Key Developments

11.9.5 SWOT Analysis

11.10 GlycoMar

11.10.1 Overview

11.10.2 Products Overview

11.10.3 Financials

11.10.4 Key Developments

11.10.5 SWOT Analysis

11.11 Cellgen Biologicals Pvt Ltd

11.11.1 Overview

11.11.2 Products Overview

11.11.3 Financials

11.11.4 Key Developments

11.11.5 SWOT Analysis

11.12 Nurture Aqua Technology Pvt. Ltd

11.12.1 Overview

11.12.2 Products Overview

11.12.3 Financials

11.12.4 Key Developments

11.12.5 SWOT Analysis

11.13 Samudra Biopharma Pvt. Ltd

11.13.1 Overview

11.13.2 Products Overview

11.13.3 Financials

11.13.4 Key Developments

11.13.5 SWOT Analysis

11.14 Cryolife, Inc.

11.14.1 Overview

11.14.2 Products Overview

11.14.3 Financials

11.14.4 Key Developments

11.14.5 SWOT Analysis

11.15 Sanosil Biotech

11.15.1 Overview

11.15.2 Products Overview

11.15.3 Financials

11.15.4 Key Developments

11.15.5 SWOT Analysis

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s Viewpoint

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Predictions for the Biosurgery Industry

Chapter 13. Appendix

LIST OF TABLES

Table 1 Global Blue Biotechnology Market Information Synopsis, 2017–2023

Table 2 Global Blue Biotechnology Market Information Estimates and Forecast, 2017–2023 (USD Million)

Table 3 Global Blue Biotechnology Market Information, by Region, 2017–2023 (USD Million)

Table 4 Global Blue Biotechnology Market Information, by Products, 2017–2023 (USD Million)

Table 5 Global Blue Biotechnology Market Information, by Application, 2017–2023 (USD Million)

Table 6 Global Blue Biotechnology Market Information, by End-users, 2017–2023 (USD Million)

Table 7 North America: Blue Biotechnology Market Information, by Products, 2017–2023 (USD

Million)

Table 8 North America: Blue Biotechnology Market Information, by Application, 2017–2023 (USD

Million)

Table 9 North America: Blue Biotechnology Market Information, by End-users, 2017–2023 (USD

Million)

Table 10 US: Blue Biotechnology Market Information, by Products, 2017–2023 (USD Million)

Table 11 US: Blue Biotechnology Market Information, by Application, 2017–2023 (USD Million)

Table 12 US: Blue Biotechnology Market Information, by End-users, 2017–2023 (USD Million)

Table 13 Canada: Blue Biotechnology Market Information, by Products, 2017–2023 (USD Million)

Table 14 Canada: Blue Biotechnology Market Information, by Application, 2017–2023 (USD Million)

Table 15 Canada: Blue Biotechnology Market Information, by End-users, 2017–2023 (USD

Million)

Table 16 South America: Blue Biotechnology Market Information, by Products, 2017–2023 (USD

Million)

Table 17 South America: Blue Biotechnology Market Information, by Application, 2017–2023 (USD

Million)

Table 18 South America: Blue Biotechnology Market Information, by End-users, 2017–2023 (USD

Million)

Table 19 Europe: Blue Biotechnology Market Information, by Products, 2017–2023 (USD Million)

Table 20 Europe: Blue Biotechnology Market Information, by Application, 2017–2023 (USD Million)

Table 21 Europe: Blue Biotechnology Market Information, by End-users, 2017–2023 (USD Million)

Table 22 Western Europe: Blue Biotechnology Market Information, by Products, 2017–2023 (USD

Million)

Table 23 Western Europe: Blue Biotechnology Market Information, by Application, 2017–2023 (USD

Million)

Table 24 Western Europe: Blue Biotechnology Market Information, by End-users, 2017–2023

(USD Million)

Table 25 Eastern Europe: Blue Biotechnology Market Information, by Products, 2017–2023 (USD

Million)

Table 26 Eastern Europe: Blue Biotechnology Market Information, by Application, 2017–2023 (USD

Million)

Table 27 Eastern Europe: Blue Biotechnology Market Information, by End-users, 2017–2023

(USD Million)

Table 28 Asia-Pacific: Blue Biotechnology Market Information, by Products, 2017–2023 (USD

Million)

Table 29 Asia-Pacific: Blue Biotechnology Market Information, by Application, 2017–2023 (USD

Million)

Table 30 Asia-Pacific: Blue Biotechnology Market Information, by End-users, 2017–2023 (USD

Million)

Table 31 Middle East & Africa: Blue Biotechnology Market Information, by Products, 2017–2023

(USD Million)

Table 32 Middle East & Africa: Blue Biotechnology Market Information, by Application, 2017–2023

(USD Million)

Table 33 Middle East & Africa: Blue Biotechnology Market Information, by End-users, 2017–2023

(USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Blue Biotechnology Market Information

Figure 3 Segmentation Market Dynamics for Global Blue Biotechnology Market Information

Figure 4 Global Blue Biotechnology Market Information Share, by Products, 2017

Figure 5 Global Blue Biotechnology Market Information Share, by Application, 2017

Figure 6 Global Blue Biotechnology Market Information Share, by End-users, 2017

Figure 7 Global Blue Biotechnology Market Information Share, by Region, 2017

Figure 8 North America: Blue Biotechnology Market Information Share, by Country, 2017

Figure 9 Europe: Blue Biotechnology Market Information Share, by Country, 2017

Figure 10 Asia-Pacific: Blue Biotechnology Market Information Share, by Country, 2017

Figure 11 Middle East & Africa: Blue Biotechnology Market Information Share, by Country, 2017

Figure 12 Global Blue Biotechnology Market Information: Company Share Analysis, 2017 (%)

Figure 13 Aker BioMarine: Key Financials

Figure 14 Aker BioMarine: Segmental Revenue

Figure 15 Aker BioMarine: Geographical Revenue

Figure 16 Marinova: Key Financials

Figure 17 Marinova: Segmental Revenue

Figure 18 Marinova: Geographical Revenue

Figure 19 New England Biolabs: Key Financials

Figure 20 New England Biolabs: Segmental Revenue

Figure 21 New England Biolabs: Geographical Revenue

Figure 22 PML Applications Ltd: Key Financials

Figure 23 PML Applications Ltd: Segmental Revenue

Figure 24 PML Applications Ltd: Geographical Revenue

Figure 25 Sea Run Holdings, Inc.: Key Financials

Figure 26 Sea Run Holdings, Inc.: Segmental Revenue

Figure 27 Sea Run Holdings, Inc.: Geographical Revenue

Figure 28 PICES: Key Financials

Figure 29 PICES: Segmental Revenue

Figure 30 PICES: Geographical Revenue

Figure 31 Donald Danforth Plant Science Center: Key Financials

Figure 32 Donald Danforth Plant Science Center: Segmental Revenue

Figure 33 Donald Danforth Plant Science Center: Geographical Revenue

Figure 34 Shell Marine Products: Key Financials

Figure 35 Shell Marine Products Segmental Revenue

Figure 36 Shell Marine Products: Geographical Revenue

Figure 37 GeoMarine Biotechnologies: Key Financials

Figure 38 GeoMarine Biotechnologies: Segmental Revenue

Figure 39 GeoMarine Biotechnologies: Geographical Revenue

Figure 40 GlycoMar: Key Financials

Figure 41 GlycoMar: Segmental Revenue

Figure 42 GlycoMar: Geographical Revenue

Figure 43 Cellgen Biologicals Pvt Ltd: Key Financials

Figure 44 Cellgen Biologicals Pvt Ltd: Segmental Revenue

Figure 45 Cellgen Biologicals Pvt Ltd: Geographical Revenue

Figure 46 Nurture Aqua Technology Pvt. Ltd: Key Financials

Figure 47 Nurture Aqua Technology Pvt. Ltd: Segmental Revenue

Figure 48 Nurture Aqua Technology Pvt. Ltd: Geographical Revenue

Figure 49 Samudra Biopharma Pvt. Ltd: Key Financials

Figure 50 Samudra Biopharma Pvt. Ltd: Segmental Revenue

Figure 51 Samudra Biopharma Pvt. Ltd: Geographical Revenue

Figure 52 Sanosil Biotech: Key Financials

Figure 53 Sanosil Biotech: Segmental Revenue

Figure 54 Sanosil Biotech: Geographical Revenue